[1] |
Siegel R, Naishadham D, Jemal A.Cancer statistics,2012.CA Cancer J Clin,2012,62:10-29.
|
[2] |
Shostak K, Zhang X, Hubert P,et al.NF-kappaB-induced KIAA1199 promotes survival through EGFR signalling.Nat Commun,2014,5:5232.
|
[3] |
Luo Q, Lin H, Ye X,et al.Trim44 facilitates the migration and invasion of human lung cancer cells via the NF-kappaB signaling pathway.Int J ClinOncol,2014.
|
[4] |
Ghonaimy EA, Shinawi M, Ibrahim SA,et al.Positive lymph-node breast cancer patients:Activation of NF-kappaB in tumor associated leukocytes stimulates cytokines secretion that promotes metastasis via CC-chemokine receptor CCR7.FEBS J,2014.
|
[5] |
Ryan AE, Colleran A, O'Gorman A,et al.Targeting colon cancer cell NF-kappaB promotes an anti-tumour M1-like macrophage phenotype and inhibits peritoneal metastasis.Oncogene,2014.
|
[6] |
Schon S, Flierman I, Ofner A,et al.beta-catenin regulates NF-kappaB activity via TNFRSF19 in colorectal cancer cells.Int J Cancer,2014,135:1800-1811.
|
[7] |
Dutta S, Wang FQ, Wu HS,et al.The NF-kappaB pathway mediates lysophosphatidic acid(LPA)-induced VEGF signaling and cell invasion in epithelial ovarian cancer(EOC).GynecolOncol,2011,123:129-137.
|
[8] |
Hwang YS, Hodge JC, Sivapurapu N,et al.Lysophosphatidic acid stimulates PC-3 prostate cancer cell Matrigel invasion through activation of RhoA and NF-kappaB activity.MolCarcinog,2006,45:518-529.
|
[9] |
McAllister-Lucas LM, Inohara N, Lucas PC,et al.Bimp1,a MAGUK family member linking protein kinase C activation to Bcl10-mediated NF-kappaB induction.J BiolChem,2001,276:30589-30597.
|
[10] |
Grabiner BC, Blonska M, Lin PC,et al.CARMA3 deficiency abrogates G protein-coupled receptor-induced NF-{kappa}B activation.Genes Dev,2007,21:984-996.
|
[11] |
Mahanivong C, Chen HM, Yee SW,et al.Protein kinase C alpha-CARMA3 signaling axis links Ras to NF-kappa B for lysophosphatidic acid-induced urokinase plasminogen activator expression in ovarian cancer cells.Oncogene,2008,27:1273-1280.
|
[12] |
Man X, He J, Kong C,et al.Clinical significance and biological roles of CARMA3 in human bladder carcinoma.TumourBiol,2014,35:4131-4136.
|
[13] |
Du S, Jia L, Zhang Y,et al.CARMA3 is upregulated in human pancreatic carcinoma,and its depletion inhibits tumor proliferation,migration,and invasion.TumourBiol,2014,35:5965-5970.
|
[14] |
Zhao T, Miao Z, Wang Z,et al.CARMA3 overexpression accelerates cell proliferation and inhibits paclitaxel-induced apoptosis through NF-kappaB regulation in breast cancer cells.TumourBiol,2013,34:3041-3047.
|
[15] |
Chaturvedi MM, Sung B, Yadav VR,et al.NF-kappaB addiction and its role in cancer:'one size does not fit all'.Oncogene,2011,30:1615-1630.
|
[16] |
Xie C, Han Y, Fu L,et al.Overexpression of CARMA3 is associated with advanced tumor stage,cell cycle progression,and cisplatin resistance in human epithelial ovarian cancer.TumourBiol,2014,35:7957-7964.
|
[17] |
Lea D, Haland S, Hagland HR,et al.Accuracy of TNM staging in colorectal cancer:a review of current culprits,the modern role of morphology and stepping-stones for improvements in the molecular era.Scand J Gastroenterol,2014,49:1153-1163.
|
[18] |
Costi R, Beggi F, Reggiani V,et al.Lymph node ratio improves TNM and Astler-Coller's assessment of colorectal cancer prognosis:an analysis of 761 node positive cases.J GastrointestSurg,2014,18:1824-1836.
|
[19] |
Kulaylat AN, Schubart JR, Stokes AL,et al.Overall survival by pattern of recurrence following curative intent surgery for colorectal liver metastasis.J SurgOncol,2014,110:1011-1015.
|
[20] |
Lumachi F, Orlando R, Marino F,et al.Expression of p53 and Ki-67 as prognostic factors for survival of men with colorectal cancer.Anticancer Res,2012,32:3965-3967.
|